Bolt Biotherapeutics (BOLT)

Bolt Biotherapeutics (BOLT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $7.7M; returns 1 day +49.6%, 1 week +56.7%, 1 year +8.9%.

Bolt Biotherapeutics (NASDAQ: BOLT) is a clinical-stage biopharmaceutical company headquartered in Redwood City, California, focused on developing novel immunotherapies for the treatment of cancer.

Groups BOLT belongs to

• Biotechnology
• Clinical Stage Biotech
• Cancer Therapeutics
• Oncology
• Immunotherapy
• Biopharmaceutical
• Clinical Stage
• Antibody-Drug Conjugates
• Healthcare
• Life Sciences
• Antibody Therapeutics

BOLT financial model: income statement, cash flow and balance sheet